Balloon Guide Versus Conventional Guide Catheter in Stroke Thrombectomy
Launched by UNIVERSITY OF SOUTH FLORIDA · Jul 17, 2025
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different tools used during a stroke treatment called thrombectomy, which helps remove a blood clot blocking blood flow in the brain. The study wants to find out if using a balloon guide catheter (a special tube that can temporarily block blood flow to help with clot removal) works better or faster than the conventional guide catheter (a more standard tube) in restoring blood flow during this procedure. Researchers hope this will help improve outcomes for people who have had an acute ischemic stroke, which happens when a blood clot blocks an artery in the brain.
Adults who have had a stroke caused by a large blood vessel blockage and are undergoing a thrombectomy may be eligible to join this study. To participate, patients or their legally authorized representatives need to agree to take part and provide some medical information and brain images collected during their usual care. Participants will have the thrombectomy procedure as planned and will be asked to answer some questions about their brain function three months after their hospital stay. This study is currently recruiting adults aged 18 and older, and it excludes those who cannot provide consent or if the thrombectomy is stopped early for any reason.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years or older
- • Patient is undergoing a stroke thrombectomy procedure at the enrolling hospital
- • Patient or the legally authorized representative are able to provide signed informed cosent for the study
- • Patient is not enrolled in another clinical trial that may interfere with the results or interpretation of this study
- • Identification of a Large Vessel Occlusion (LVO) on imaging
- Exclusion Criteria:
- • Lack of signed informed consent from the patient or legally authorized representative
- • Spontanous recanalization or any other reason in which the mechanical thrombectomy procedure would be terminated
About University Of South Florida
The University of South Florida (USF) is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a strong commitment to improving patient outcomes, USF leverages its diverse faculty expertise and state-of-the-art facilities to conduct rigorous and ethically sound research. The university fosters collaboration across disciplines, engaging in partnerships that enhance the translation of scientific discoveries into effective therapeutic interventions. USF's clinical trial programs are designed to address pressing health challenges and contribute to the body of knowledge in various medical fields, ultimately aiming to benefit communities and improve public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tampa, Florida, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported